Vasospastic Angina Management with Calcium Channel Blockers

Guideline Recommendations

The European Society of Cardiology recommends calcium channel blockers for patients with vasospastic angina, with all subclasses causing similar coronary vasodilation 1
The American Heart Association recommends long-acting calcium channel blockers and nitrates for patients with coronary artery spasm (Class I) 2
The American College of Cardiology states that all calcium-channel blockers are effective alone or in combination with nitrates in the treatment of vasospastic angina, with similar antianginal efficacy across all agents 3, 4, 5

Diltiazem has less peripheral vasodilatory effect compared to dihydropyridines but produces significant negative chronotropic and dromotropic effects, according to the European Heart Journal 1, 6
The European Society of Cardiology prefers diltiazem when heart rate control is needed or in patients with supraventricular tachyarrhythmias, as it directly affects cardiac pacemaker and AV conduction cells 3, 7
Amlodipine produces the most marked peripheral arterial vasodilation with minimal direct effects on heart rate, contractility, or AV conduction, as reported in the European Heart Journal and Circulation 1, 6, 2

The American College of Cardiology recommends choosing diltiazem when the patient has elevated heart rate (>70-80 bpm) requiring rate control, or concurrent supraventricular arrhythmias or atrial fibrillation, or hypertrophic cardiomyopathy 3, 7
The American Heart Association suggests choosing amlodipine when the patient has bradycardia or conduction abnormalities (PR >0.24 seconds, AV block), or requires concurrent phosphodiesterase-5 inhibitor therapy (sildenafil, tadalafil), or has LV dysfunction or heart failure 2, 6, 8

The American Heart Association advises against using immediate-release nifedipine without beta-blocker therapy (Class III: Harm), as it increases mortality in ACS patients 6, 2
The European Society of Cardiology warns against combining diltiazem with ivabradine, as both are metabolized by CYP3A4 and cause severe bradycardia risk 3, 7
Both the American College of Cardiology and the European Society of Cardiology note that both agents can cause hypotension—monitor blood pressure closely, especially in elderly patients or those with pre-existing cardiovascular disease 3, 8

The American Heart Association/American College of Cardiology recommends calcium channel blockers (CCBs) as first-line therapy for vasospastic angina, with the option to add a second CCB (specifically a dihydropyridine like amlodipine) when symptoms persist despite initial CCB therapy 9, 10
The American Heart Association/American College of Cardiology guidelines position non-dihydropyridine CCB (verapamil or diltiazem) as the recommended first-line agent for vasospastic angina 9, 10
For patients with persistent symptoms, the American Heart Association/American College of Cardiology guidelines recommend adding a long-acting nitrate or a dihydropyridine CCB (e.g., amlodipine) as second-line therapy 9, 10

The European Society of Cardiology notes that amlodipine produces marked peripheral arterial vasodilation and will address both the vasospastic angina AND the hypertension simultaneously 11
The European Society of Cardiology recommends monitoring blood pressure closely, with a target of <130/80 mmHg, but avoiding dropping systolic BP below 130 mmHg (J-curve phenomenon in CAD patients) 12

The European Heart Journal reports that ranolazine has no significant effect on heart rate or blood pressure, so it will not address the patient's hypertension 11
The European Heart Journal notes that the MERLIN-TIMI 36 trial showed ranolazine was not effective in reducing major cardiovascular events 11

The American Heart Association/American College of Cardiology guidelines recommend adding a long-acting nitrate (isosorbide mononitrate 10 mg BID) as the next step if amlodipine fails 9, 10
The American Heart Association/American College of Cardiology guidelines recommend considering ranolazine only after both CCB combination AND nitrates have failed 9, 10